<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=undefined&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Pharmacogenetics of osteoporosis

Name: Pharmacogenetics of osteoporosis
Keywords: Selective Estrogen Receptor Modulators, Osteoporosis; Pharmacogenetics, Bone Density Conservation Agents, Parathyroid Hormone, Humans, Osteoporosis, anti-fracturative drugs; drug response; gene polymorphism; osteoporosis; pharmacogenetics, Review Article, Denosumab, Antibodies, Monoclonal, Humanized

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 19 Aug 2010 Italy Publisher:Elsevier BVJournal:Best Practice & Research Clinical Endocrinology & Metabolism, volume 28, pages 783-793 (issn: 1521-690X,

Authors: MARINI, FRANCESCA; BRANDI, MARIA LUISA;

doi: 10.1016/j.beem.2014.07.004 , 10.1586/eem.10.67 , 10.3410/b2-63

pmid: 21173854 , 25432352 , 30780823

pmc: PMC2990451

handle: 2158/872737 , 2158/932130 , 2158/551273

Pharmacogenetics of osteoporosis

- Summary
- Subjects
- Metrics

Abstract

Osteoporosis is a complex bone disorder with a strong genetic basis. The genetics of osteoporosis encompasses two main areas: genetics of disease susceptibility and pharmacogenetics of drug response. The former has been widely studied in the past few decades, while the latter is still largely untouched. This review will provide an overview of the pharmacogenetics of osteoporosis, focusing on the major recent advances in the past two years.

Country

Italy

Related Organizations

Università degli studi di Salerno
Italy
University of Florence
Italy

Keywords

Selective Estrogen Receptor Modulators, Osteoporosis; Pharmacogenetics, Bone Density Conservation Agents, Parathyroid Hormone, Humans, Osteoporosis, anti-fracturative drugs; drug response; gene polymorphism; osteoporosis; pharmacogenetics, Review Article, Denosumab, Antibodies, Monoclonal, Humanized

Impact byBIP!

	citations This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	20
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average

Found an issue? Give us feedback

Top 10%

Average

Green

gold

Beta

SDGs Suggest

3. Good health

Beta

SDGs:

3. Good health,

Related to Research communities

Knowmad Institut